| Literature DB >> 35456582 |
Adrián Sánchez1, Carlos J Carrasco1, Francisco Montilla1, Eleuterio Álvarez2, Agustín Galindo1, María Pérez-Aranda3,4, Eloísa Pajuelo4, Ana Alcudia3.
Abstract
Complexes {Ag[NHCMes,R]}n (R = H, 2a; Me, 2b and 2b'; iPr, 2c; iBu, 2d), were prepared by treatment of imidazolium precursor compounds [ImMes,R] (2-(3-mesityl-1H-imidazol-3-ium-1-yl)acetate, 1a, (S)-2-alkyl(3-mesityl-1H-imidazol-3-ium-1-yl)acetate, 1b-d, and (R)-2-methyl(3-mesityl-1H-imidazol-3-ium-1-yl)acetate, 1b', with Ag2O under appropriate conditions. They were characterised by analytical, spectroscopic (IR, 1H, and 13C NMR and polarimetry), and X-ray methods (2a). In the solid state, 2a is a one-dimensional coordination polymer, in which the silver(I) cation is bonded to the carbene ligand and to the carboxylate group of a symmetry-related Ag[NHCMes,H] moiety. The coordination environment of the silver centre is well described by the DFT study of the dimeric model {Ag[NHCMes,H]}2. The antimicrobial properties of these complexes were evaluated versus Gram-negative bacteria E. coli and P. aeruginosa. From the observed MIC and MBC values (minimal inhibitory concentration and minimal bactericidal concentration, respectively), complex 2b' showed the best antimicrobial properties (eutomer), which were significantly better than those of its enantiomeric derivative 2b (distomer). Additionally, analysis of MIC and MBC values of 2a-d reveal a clear structure-antimicrobial effect relationship. Antimicrobial activity decreases when the steric properties of the R alkyl group in {Ag[NHCMes,R]}n increase.Entities:
Keywords: amino acid; antimicrobial; chiral; imidazolium-carboxylate; silver complexes
Year: 2022 PMID: 35456582 PMCID: PMC9024828 DOI: 10.3390/pharmaceutics14040748
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
Scheme 1Synthesis of compounds 2.
Figure 1(a) Asymmetric unit of complex 2a. (b) Coordination around silver atom in 2a. (c) Coordination 1D polymer formed by 2a viewed along c axis.
Antimicrobial activities of the 2 complexes and AgNO3 evaluated by MIC and MBC (mM).
|
|
| |||
|---|---|---|---|---|
| Complex | MIC | MBC | MIC | MBC |
|
| 0.156 | 0.625 | 0.078 | 0.3125 |
|
| 0.156 | 0.3125 | 0.156 | 0.625 |
|
| 0.078 | 0.156 | 0.039 | 0.156 |
|
| 0.3125 | 1.250 | 0.3125 | 2.500 |
|
| 1.250 | 2.500 | 1.250 | 2.500 |
|
| 0.156 | 0.3125 | 0.156 | 0.3125 |
Antioxidant enzyme activity (mU·mg−1 protein) of complexes 2b and 2c in E. coli and P. aeruginosa assays a.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
| Complex | Enzyme | Control | MIC | MBC | Control | MIC | MBC |
|
| Catalase | ND b | 2.5 × 10−5 ± 0.2 × 10−5 | 6.6 × 10−5 ± 0.9 × 10−5 | ND | ND | ND |
| Peroxidases | ND | ND | ND | ND | ND | 0.002 ± 0.001 | |
| Superoxide dismutase | 3.33 ± 0.01 | 1.51 ± 0.07 | 92.1 ± 2.3 | 3.40 ± 0.06 | 20.00 ± 0.01 | 76.3 ± 0.1 | |
|
| Catalase | ND | 5.5 × 10−5 ± 0.1 × 10−5 | 8.3 × 10−5 ± 0.1 × 10−5 | ND | ND | ND |
| Peroxidases | 0.48 ± 0.05 | 0.16 ± 0.02 | 0.03 ± 0.01 | 0.38 ± 0.03 | 1.1 ± 0.1 | 2.5 ± 0.3 | |
| Superoxide dismutase | 3.33 ± 0.01 | 4.14 ± 0.07 | 3.66 ± 0.06 | 3.40 ± 0.06 | 9.1 ± 0.1 | 20.0 ± 0.2 | |
a Data are means ± standard deviations of three independent determinations. b ND = not detected.
Determination of the onset inhibitory concentration (mM) of biofilm formation for complexes 2b and 2c in comparison to MIC (mM).
|
|
| |||
|---|---|---|---|---|
| Complex | MIC | Onset Inhibitory Concentration of Biofilm | MIC | Onset Inhibitory Concentration of Biofilm |
|
| 0.156 | 0.039 | 0.156 | 0.020 |
|
| 0.313 | 0.313 | 0.313 | 0.313 |
Relative energies (ΔG, kcal·mol−1) of [ImMes,R], 1, and [ImAr’,Me] and their carbene isomers.
|
|
|
|
| H | 0 | 9.4 |
| Me | 0 | 8.9 |
| 0 | 7.0 | |
| CH2 | 0 | 9.0 |
|
|
|
|
| NH2 | 0 | 10.7 |
| OH | 0 | 9.4 |
| Me | 0 | 7.8 |
| H | 0 | 7.2 |
| F | 0 | 6.3 |
| Cl | 0 | 6.0 |
Figure 2Correlation between the Hammett parameter of the p-substituent of the aryl group and the relative energy difference between the carbene isomer and the stable form of [ImAr’,Me].
Figure 3Optimised structure of the dimeric model 2a.
Figure 4Selected MOs of [NHCMes,H]− ligand.